Aleva Neurotherapeutics SA of Switzerland has raised CHF 4 million (€3.3 million) in a Series B financing round to advance development of its implant technology for deep brain stimulation. The round was led by Banexi Ventures Partners. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
